A Real-time Fluorescence Polarization Activity Assay to Screen for Inhibitors of Bacterial Ribonuclease P
Overview
Authors
Affiliations
Ribonuclease P (RNase P) is an essential endonuclease that catalyzes the 5' end maturation of precursor tRNA (pre-tRNA). Bacterial RNase P is an attractive potential antibacterial target because it is essential for cell survival and has a distinct subunit composition compared to the eukaryal counterparts. To accelerate both structure-function studies and discovery of inhibitors of RNase P, we developed the first real-time RNase P activity assay using fluorescence polarization/anisotropy (FP/FA) with a 5' end fluorescein-labeled pre-tRNAAsp substrate. This FP/FA assay also detects binding of small molecules to pre-tRNA. Neomycin B and kanamycin B bind to pre-tRNAAsp with a Kd value that is comparable to their IC50 value for inhibition of RNase P, suggesting that binding of these antibiotics to the pre-tRNA substrate contributes to the inhibitory activity. This assay was optimized for high-throughput screening (HTS) to identify specific inhibitors of RNase P from a 2880 compound library. A natural product derivative, iriginol hexaacetate, was identified as a new inhibitor of Bacillus subtilis RNase P. The FP/FA methodology and inhibitors reported here will further our understanding of RNase P molecular recognition and facilitate discovery of antibacterial compounds that target RNase P.
Studying Exoribonuclease Activity Using Fluorescence Anisotropy Assay.
Kus K, Vasiljeva L Methods Mol Biol. 2024; 2863:71-80.
PMID: 39535705 DOI: 10.1007/978-1-0716-4176-7_6.
Targeting Ribonucleases with Small Molecules and Bifunctional Molecules.
Borgelt L, Wu P ACS Chem Biol. 2023; 18(10):2101-2113.
PMID: 37382390 PMC: 10594538. DOI: 10.1021/acschembio.3c00191.
Overview on Strategies and Assays for Antibiotic Discovery.
Rutten A, Kirchner T, Musiol-Kroll E Pharmaceuticals (Basel). 2022; 15(10).
PMID: 36297414 PMC: 9607151. DOI: 10.3390/ph15101302.
Hernandez S, Feracci M, De Jesus C, El Kazzi P, Kaci R, Garlatti L Antiviral Res. 2022; 204:105364.
PMID: 35716929 PMC: 9212739. DOI: 10.1016/j.antiviral.2022.105364.
RNase P Inhibitors Identified as Aggregators.
Schencking I, Schafer E, Scanlan J, Wenzel B, Emmerich R, Steinmetzer T Antimicrob Agents Chemother. 2021; 65(8):e0030021.
PMID: 33972249 PMC: 8284443. DOI: 10.1128/AAC.00300-21.